Last reviewed · How we verify
NCT06170437
Smoke-free Home Study in Subsidized Housing
NA trial testing Smoke-free home resident intervention in Tobacco Dependence in 544 participants. Currently enrolling.
31 December 2026
Quick facts
| Lead sponsor | University of California, San Francisco |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 544 |
| Start date | 12 July 2024 |
| Primary completion | 31 December 2026 |
| Estimated completion | 31 August 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Smoke-free home resident intervention
- Lay Health Worker coaching
Conditions studied
- Tobacco Dependence — all drugs for Tobacco Dependence →
- Tobacco Smoking — all drugs for Tobacco Smoking →
Sponsor
University of California, San Francisco
Who can join
18 and older, any sex, with Tobacco Dependence or Tobacco Smoking. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Comprehensive smoke-free policies have the potential to substantially reduce tobacco-related disparities among populations in subsidized housing. This study fills this gap by identifying approaches to increase the implementation of smoke-free policies in all types of subsidized housing by increasing the voluntary adoption of smoke-free homes and promoting access to smoking cessation services.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The Healthy Homes Study: Protocol for a cluster randomized trial of a place-based smoke-free home intervention in affordable housing.
Hawes MR, Chakravarty D, Cheng J, Handley MA, et al · · 2025 · PMID 40729126 · DOI 10.1371/journal.pone.0328786
Verify or expand the search:
- PubMed search for NCT06170437
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Tobacco Dependence
Currently open trials in the same condition.
- NCT07220356 — C-Raven, a Virtual Tobacco Cessation Intervention in Residency Clinics · Phase 4 · recruiting
- NCT07148232 — Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness · Phase 4 · recruiting
- NCT06881069 — Reach Through Equitable Implementation in Utah · NA · recruiting
- NCT06488443 — Effect of Yoga on Reducing Craving in Tobacco Dependent Individuals · NA · recruiting
- NCT06218056 — Cannabidiol for Reducing Cigarette Use · Phase 2 · recruiting
Other University of California, San Francisco trials
Trials by the same sponsor.
- NCT05284773 — Screening for Acute Malnutrition · NA · withdrawn
- NCT04634851 — Video Home Visits for Dietary Counselling · NA · not yet recruiting
- NCT06065670 — Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a M · Phase 1, PHASE2 · not yet recruiting
- NCT07534098 — Intervention for Hearing Health Among Native Americans · NA · not yet recruiting
- NCT06960421 — Exercise-based Frailty Intervention in Lung Transplantation (XFIT) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06170437 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of California, San Francisco
- Last refreshed: 24 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06170437.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing